HOXA13 and esophageal squamous cell carcinoma: The combined aberrant expression of HOXA13/HOTTIP related to the promotion of cell proliferation and in vivo/in vitro metastases, has been also reported in ESCC cells [63] and in non-small-cell-lung cancer (NSCLC) [64].